← Browse by Condition
Medical Condition

relapsed or refractory t cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05079282 Phase 1
Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Enrollment
217 pts
Location
United States
Sponsor
Ono Pharmaceutical Co. Ltd
View Trial →